Carregant...
Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
MDSC undergo metabolic reprogramming in the tumor resulting in an increased fatty acid β oxidation that supports their immunosuppressive functions. Fatty acid oxidation inhibitors, used to treat coronary disease, significantly delayed tumor growth and had a significantly increased antitumor effect w...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007951/ https://ncbi.nlm.nih.gov/pubmed/27622069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1200771 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|